Abstract

In recent years, microglia have attracted attention owing to their roles in various neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Microglia, which are brain-resident macrophages, not only act as immune cells but also perform other functions in the body. Interestingly, they exert contrasting effects on different neurodegenerative diseases. In addition to the previously reported M1 (toxic) and M2 (protective) types, microglia now also include disease-associated microglia owing to a more elaborate classification. Understanding this detailed classification is necessary to elucidate the association between microglia and neurodegenerative diseases. In this review, we discuss the diverse roles of microglia in neurodegenerative diseases and highlight their potential as therapeutic targets.

MeSH

Classification, Neurodegenerative Diseases, Microglia

Cited by

• Revolutionizing Neuroimmunology: Unraveling Immune Dynamics and Therapeutic Innovations in CNS Disorders. Int J Mol Sci, 2025
• Brain Neurotrophins and Plant Polyphenols: A Powerful Connection. Molecules, 2025
• Single Nuclei Transcriptomics Reveals Obesity-Induced Endothelial and Neurovascular Dysfunction: Implications for Cognitive Decline. Int J Mol Sci, 2024
• In Vitro and In Vivo Antioxidant and Immune Stimulation Activity of Wheat Product Extracts. Nutrients, 2025
• Role of glial cells in motor neuron degeneration in hereditary spastic paraplegias. Front Cell Neurosci, 2025
• The effects of Chinese Buddhist meditation tradition: the impact of nature observation and literary creation. Front Psychol, 2025
• A Human Brain-Chip for Modeling Brain Pathologies and Screening Blood-Brain Barrier Crossing Therapeutic Strategies. Pharmaceutics, 2024
• Microglial xCT Is a Novel Therapeutic Target for Traumatic Brain Injury in Model Mice. Yonago Acta Med, 2025